Prodromal Parkinson's disease and the catecholaldehyde hypothesis: Insight from olfactory bulb organotypic cultures

Area of Science:

• Neuroscience
• Molecular Biology
• Pathology

Background:

• Parkinson's disease (PD) is a progressive neurodegenerative disorder with unknown etiology and no cure.
• Early pathological changes in the olfactory bulb (OB), crucial for initial olfactory processing, are observed in PD, yet cellular mechanisms remain unclear.
• Understanding the prodromal phase of PD is critical for developing disease-modifying therapies.

Purpose of the Study:

• To investigate the effects of 3,4-dihydroxyphenylacetylaldehyde (DOPAL), a dopamine metabolite implicated in PD pathogenesis, on olfactory bulb cells.
• To develop and characterize organotypic and primary olfactory bulb cultures as models for studying early PD.
• To explore the role of the olfactory bulb in PD progression using cellular models.

Main Methods:

• Development and characterization of organotypic and primary olfactory bulb (OB) cultures.
• Exposure of OB cultures to 3,4-dihydroxyphenylacetylaldehyde (DOPAL).
• Assessment of cellular and molecular changes, including oxidative stress, mitochondrial membrane potential, neurodegeneration, and transcriptomic alterations.

Main Results:

• DOPAL exposure in OB cultures replicated key aspects of Parkinson's disease pathology.
• DOPAL induced oxidative stress, mitochondrial membrane depolarization, and neurodegeneration in olfactory bulb cells.
• Transcriptomic changes observed in DOPAL-treated cultures were consistent with those reported in clinical Parkinson's disease studies.

Conclusions:

• The findings support the catecholaldehyde hypothesis of Parkinson's disease.
• Olfactory bulb models provide valuable insights into the mechanisms underlying early PD pathogenesis.
• DOPAL's detrimental effects on olfactory bulb cells highlight its potential role in PD progression.